Total Assets Summary of Genmab A/S

Genmab A/S's latest annual total assets in 2023 was 35.28 Billion DKK , up 16.55% from previous year.
Genmab A/S's latest quarterly total assets in 2024 Q2 was 38.61 Billion DKK , up 5.29% from previous quarter.
Genmab A/S reported annual total assets of 30.27 Billion DKK in 2022, up 22.95% from previous year.
Genmab A/S reported annual total assets of 24.62 Billion DKK in 2021, up 16.48% from previous year.
Genmab A/S reported quarterly total assets of 38.61 Billion DKK for 2024 Q2, up 5.29% from previous quarter.
Genmab A/S reported quarterly total assets of 30.39 Billion DKK for 2023 Q1, up 0.38% from previous quarter.

Annual Total Assets Chart of Genmab A/S (2023 - 2002)

Historical Annual Total Assets of Genmab A/S (2023 - 2002)

Year	Total Assets	Total Assets Growth
2023	35.28 Billion DKK	16.55%
2022	30.27 Billion DKK	22.95%
2021	24.62 Billion DKK	16.48%
2020	21.14 Billion DKK	39.61%
2019	15.14 Billion DKK	78.99%
2018	8.46 Billion DKK	28.14%
2017	6.6 Billion DKK	26.05%
2016	5.23 Billion DKK	34.23%
2015	3.9 Billion DKK	36.13%
2014	2.86 Billion DKK	65.56%
2013	1.73 Billion DKK	2.28%
2012	1.69 Billion DKK	8.21%
2011	1.56 Billion DKK	-36.96%
2010	2.48 Billion DKK	11.71%
2009	2.22 Billion DKK	-31.83%
2008	3.25 Billion DKK	-17.68%
2007	3.95 Billion DKK	119.37%
2006	1.8 Billion DKK	31.68%
2005	1.37 Billion DKK	7.75%
2004	1.27 Billion DKK	7.78%
2003	1.18 Billion DKK	-25.46%
2002	1.58 Billion DKK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	36.68 Billion DKK	3.94%
2024 Q2	38.61 Billion DKK	5.29%
2023 Q1	30.39 Billion DKK	0.38%
2023 Q2	31.97 Billion DKK	5.21%
2023 Q3	35.23 Billion DKK	10.19%
2023 FY	35.28 Billion DKK	16.55%
2023 Q4	35.28 Billion DKK	0.14%
2022 Q4	30.27 Billion DKK	-1.33%
2022 Q1	24.91 Billion DKK	1.17%
2022 Q2	27.47 Billion DKK	10.28%
2022 Q3	30.68 Billion DKK	11.68%
2022 FY	30.27 Billion DKK	22.95%
2021 Q1	22.21 Billion DKK	5.05%
2021 FY	24.62 Billion DKK	16.48%
2021 Q4	24.62 Billion DKK	2.68%
2021 Q2	22.48 Billion DKK	1.23%
2021 Q3	23.98 Billion DKK	6.68%
2020 FY	21.14 Billion DKK	39.61%
2020 Q1	15.3 Billion DKK	1.05%
2020 Q2	20.68 Billion DKK	35.16%
2020 Q3	21.52 Billion DKK	4.06%
2020 Q4	21.14 Billion DKK	-1.76%
2019 Q1	8.73 Billion DKK	3.24%
2019 Q4	15.14 Billion DKK	13.61%
2019 FY	15.14 Billion DKK	78.99%
2019 Q2	8.97 Billion DKK	2.78%
2019 Q3	13.33 Billion DKK	48.49%
2018 Q3	7.4 Billion DKK	2.83%
2018 Q1	6.78 Billion DKK	2.73%
2018 FY	8.46 Billion DKK	28.14%
2018 Q4	8.46 Billion DKK	14.28%
2018 Q2	7.19 Billion DKK	6.14%
2017 Q3	5.89 Billion DKK	-2.21%
2017 Q2	6.02 Billion DKK	11.52%
2017 Q1	5.4 Billion DKK	3.19%
2017 FY	6.6 Billion DKK	26.05%
2017 Q4	6.6 Billion DKK	12.01%
2016 Q2	4.12 Billion DKK	5.55%
2016 Q1	3.91 Billion DKK	0.22%
2016 Q3	4.35 Billion DKK	5.44%
2016 Q4	5.23 Billion DKK	20.33%
2016 FY	5.23 Billion DKK	34.23%
2015 FY	3.9 Billion DKK	36.13%
2015 Q4	3.9 Billion DKK	11.47%
2015 Q3	3.5 Billion DKK	6.62%
2015 Q2	3.28 Billion DKK	3.42%
2015 Q1	3.17 Billion DKK	10.76%
2014 Q1	2.79 Billion DKK	61.22%
2014 FY	2.86 Billion DKK	65.56%
2014 Q4	2.86 Billion DKK	1.26%
2014 Q3	2.83 Billion DKK	4.16%
2014 Q2	2.71 Billion DKK	-2.64%
2013 FY	1.73 Billion DKK	2.28%
2013 Q2	1.67 Billion DKK	-4.49%
2013 Q3	1.79 Billion DKK	7.22%
2013 Q4	1.73 Billion DKK	-3.64%
2013 Q1	1.75 Billion DKK	3.65%
2012 Q1	1.45 Billion DKK	-6.7%
2012 FY	1.69 Billion DKK	8.21%
2012 Q3	1.77 Billion DKK	24.99%
2012 Q4	1.69 Billion DKK	-4.47%
2012 Q2	1.41 Billion DKK	-2.86%
2011 Q2	2.05 Billion DKK	-6.8%
2011 Q4	1.56 Billion DKK	-6.48%
2011 Q3	1.67 Billion DKK	-18.51%
2011 FY	1.56 Billion DKK	-36.96%
2011 Q1	2.2 Billion DKK	-11.24%
2010 Q4	2.48 Billion DKK	0.95%
2010 Q1	2.08 Billion DKK	-6.31%
2010 FY	2.48 Billion DKK	11.71%
2010 Q2	1.95 Billion DKK	-6.07%
2010 Q3	2.45 Billion DKK	25.75%
2009 Q4	2.22 Billion DKK	0.0%
2009 FY	2.22 Billion DKK	-31.83%
2008 FY	3.25 Billion DKK	-17.68%
2007 FY	3.95 Billion DKK	119.37%
2006 FY	1.8 Billion DKK	31.68%
2005 FY	1.37 Billion DKK	7.75%
2004 FY	1.27 Billion DKK	7.78%
2003 FY	1.18 Billion DKK	-25.46%
2002 FY	1.58 Billion DKK	0.0%

Peer Total Assets Comparison of Genmab A/S

Name	Total Assets	Total Assets Difference
ALK-Abelló A/S	6.72 Billion DKK	-424.665%
Bavarian Nordic A/S	14.35 Billion DKK	-145.861%
Gubra A/S	625.28 Million DKK	-5543.712%
Novo Nordisk A/S	314.48 Billion DKK	88.779%
Orphazyme A/S	19.31 Million DKK	-182630.944%
Pharma Equity Group A/S	81.33 Million DKK	-43287.226%
Zealand Pharma A/S	3.19 Billion DKK	-1003.17%

Global Stocks Search

Genmab A/S (GMAB.CO)

Total Assets Summary of Genmab A/S

Annual Total Assets Chart of Genmab A/S (2023 - 2002)

Historical Annual Total Assets of Genmab A/S (2023 - 2002)

Peer Total Assets Comparison of Genmab A/S